Ondas (ONDS) stock rises after $1 billion above-market financing — here’s what traders are parsing
9 January 2026
1 min read

Ondas (ONDS) stock rises after $1 billion above-market financing — here’s what traders are parsing

New York, Jan 9, 2026, 12:23 EST — Regular session

  • ONDS up about 3% in midday trade after company priced a $1 billion stock-and-warrant sale
  • Deal includes 19 million shares and pre-funded warrants tied to 60.79 million “common stock equivalents”
  • Friday SEC filing also disclosed unaudited financial snapshot for Sentry CS, a recent acquisition

Ondas Holdings Inc. shares rose about 3% on Friday, trading at $14.44, after the company said it priced a $1 billion registered direct offering of stock and warrants.

The financing is a big swing for a company that has traded with sharp moves and thin conviction at times. It brings in fresh capital quickly, but it also puts the share count — and the overhang from warrants — front and center again.

Investors tend to like cash coming in above the last close. They also worry about what comes with it: dilution, a heavy block of new paper, and a deal structure that can keep a lid on the stock if holders sell into strength.

Ondas said the offering was priced at $16.45 per share, a roughly 17.5% premium to the Jan. 8 close, and will include 19 million shares plus pre-funded warrants to buy up to about 41.79 million shares. The securities are being sold with warrants to buy a total of about 121.58 million shares at $28 each, exercisable immediately and expiring seven years from issuance, the company said. 1

In a separate catalyst, a U.S. SEC filing on Friday provided summary, unaudited financial information for Sentry CS Ltd, the Israeli counter-drone company Ondas bought in November. The filing showed Sentry reported about $11.35 million in sales and a $13.51 million net loss for the year ended Dec. 31, 2024, and about $10.98 million in sales with a $4.54 million net loss for the six months ended June 30, 2025.

That kind of disclosure can matter for a roll-up story. It gives investors a first, rough look at a business Ondas is betting on, even as the company warns the figures are preliminary and unaudited.

Next week brings two investor-facing dates that could move the stock again. Ondas is scheduled to appear at the Needham Growth Conference on Jan. 14 in a fireside chat with Needham’s Austin Bohlig, the company said. 2

Ondas has also set an investor day for Jan. 16, when it plans to lay out strategy and a financial outlook, according to the company. 3

But the near-term risk is straightforward: the financing is large, it still needs to close, and the warrants are a long-dated overhang that may not turn into cash unless the stock can clear the $28 strike. Traders will be watching for signs the deal tightens the story — or just adds supply.

The next catalysts are the expected closing of the financing on or about Jan. 12 and management’s Jan. 16 investor day.

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Thermo Fisher stock rises after Stifel lifts target to $700 as earnings near
Previous Story

Thermo Fisher stock rises after Stifel lifts target to $700 as earnings near

Compass stock jumps nearly 9% as Anywhere merger closes — here’s what traders watch next
Next Story

Compass stock jumps nearly 9% as Anywhere merger closes — here’s what traders watch next

Go toTop